Related Experiment Video
Updated: Aug 19, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
[Therapeutic approaches to increased bone resorption]
1Department of Nuclear Medicine, Kawasaki Medical School.
Abstract:
The accelerated bone resorption contributes significantly to the pathophysiology of diseases such as osteoporosis, Paget's disease, hypercalcemia, bone metastasis, and inflammation of bone associated with rheumatoid arthritis. Several antiresorptive agents have been validated as a means to control bone resorption in these diseases. A recent understanding of the molecular mechanism of osteoclastic bone resorption is providing opportunities for developing novel antiresorptive agents.
Insights
Accelerated bone resorption drives diseases like osteoporosis. Understanding osteoclast mechanisms offers new ways to develop bone resorption inhibitors.
Area of Science:
- Bone biology and disease pathology
- Molecular mechanisms of osteoclast function
Context:
- Accelerated bone resorption is central to diseases including osteoporosis, Paget's disease, hypercalcemia, bone metastasis, and rheumatoid arthritis-associated bone inflammation.
- Existing antiresorptive agents are used to manage bone resorption in these conditions.
Purpose:
- To highlight the significance of accelerated bone resorption in various bone diseases.
- To underscore the potential for novel therapeutic strategies based on recent molecular insights.
Summary:
- Osteoclast-mediated bone resorption is a key factor in the pathology of numerous skeletal disorders.
- Current treatments focus on antiresorptive agents to control excessive bone breakdown.
- Emerging knowledge of osteoclastic molecular pathways presents new avenues for drug development.
Impact:
- Provides a foundation for developing targeted therapies for bone diseases.
- Emphasizes the importance of understanding molecular mechanisms for therapeutic innovation in bone resorption.
- Contributes to the ongoing search for more effective treatments for conditions characterized by bone loss or damage.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling and Repair
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
